5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of immune-related adverse events (irAEs) in a phase 3 trial of ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel mCRPC
    Meeting Abstract

    Beer, T. M.; Logothetis, C.; Gerritsen, W. R.; Kwon, E. D.; Scher, H. I.; Bossi, A.; Van Den Eertwegh, A. J. M.; Drake, C. G.; McHenry, B.; Liu, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study
    Meeting Abstract

    Beer, T. M.; Armstrong, A. J.; Sternberg, C. N.; Higano, C. S.; Iversen, P.; Loriot, Y.; Rathkopf, D. E.; Bhattacharya, S.; Carles, J.; de Bono, J. S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis
    Meeting Abstract

    Bastos, D. A.; Molina, A. M.; Jia, X. Y.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with prostate cancer and parenchymal brain metastases (PBM)
    Meeting Abstract

    Bambury, R. M.; Hatzoglou, V.; Curtis, K. R.; Patel, G. V.; Scher, H. I.; Young, R. J.; Morris, M. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+urothelial cancer
    Meeting Abstract

    Bajorin, D. F.; Sharma, P.; Gomella, L. G.; Plimack, E. R.; O'Donnell, P. H.; Hoffman-Censits, J. H.; Flaig, T. W.; Quinn, D. I.; Sims, R. B.; Locker, M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Anand, A.; Krupa, R.; Louw, J.; Arslan, Z.; Dittamore, R.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Projected supply of and demand for oncologists and radiation oncologists through 2025: An aging, better-insured population will result in shortage
    Journal Article

    Yang, W.; Williams, J. H.; Hogan, P. F.; Bruinooge, S. S.; Rodriguez, G. I.; Kosty, M. P.; Bajorin, D. F.; Hanley, A.; Muchow, A.; McMillan, N.; more...
    Journal of Oncology Practice (2014)

    Fulltext@MSK | Save
  • Where do patients with cancer in Iowa receive radiation therapy?
    Journal Article

    Ward, M. M.; Ullrich, F.; Matthews, K.; Rushton, G.; Tracy, R.; Goldstein, M. A.; Bajorin, D. F.; Kosty, M. P.; Bruinooge, S. S.; Hanley, A.; more...
    Journal of Oncology Practice (2014)

    Fulltext@MSK | Save
  • Access to chemotherapy services by availability of local and visiting oncologists
    Journal Article

    Ward, M. M.; Ullrich, F.; Matthews, K.; Rushton, G.; Tracy, R.; Bajorin, D. F.; Goldstein, M. A.; Kosty, M. P.; Bruinooge, S. S.; Hanley, A.; more...
    Journal of Oncology Practice (2014)

    Fulltext@MSK | Save